(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Maʻemaʻe ≥98.0% (HPLC) Rivaroxaban Intermediate Factory

ʻO ka wehewehe pōkole:

Inoa Kemika: (S)-(+)-Glycidyl Phthalimide

CAS: 161596-47-0

Ke 'ano: Pada ke'oke'o i ka pauka ke'oke'o

Maʻemaʻe: ≥98.0% (HPLC)

Ka waena o Rivaroxaban (CAS: 366789-02-8) i ka mālama ʻana i ka Venous Thromboembolism (VTE)

Inquiry: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Mea Hana Mea Hana Rivaroxaban Nā Kūwaena Pili:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4-(4-Aminophenyl)morpholin-3-hoʻokahi CAS 438056-69-0
Rivaroxaban Intermediate CAS 446292-07-5
5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
Rivaroxaban API CAS 366789-02-8

Na Waiwai Kemika:

Inoa Kimia	(S)-(+)-Glycidyl Phthalimide
Nā huaʻōlelo like	(S)-Glycidyl Phthalimide;(S)-N-Glycidylphthalimide;Rivaroxaban Intermediate
Helu CAS	161596-47-0
Helu CAT	RF-PI128
Kūlana Kūʻai	Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala	C11H9NO3
Kaumaha Molecular	203.19
Lae hehee	102 ℃
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Keʻokeʻo a hiki i ka pauda keʻokeʻo
ʻIkepili	HPLC
Nalo ma ka maloo	≤0.50%
Lehu Sulphate	≤0.50%
Maʻemaʻe / Kaʻina Hanana	≥98.0% (HPLC)
Phthalimide	≤0.10%
Hoʻokahi Max ʻinoʻino	≤0.50%
Huina paumaele	≤2.0%
Epichlorohydrin	≤0.10%
ʻO Glycidol	≤0.10%
Maʻemaʻe Chiral	R-isomer ≤2.0% (HPLC)
Kūlana hoʻāʻo	Kūlana ʻoihana
Hoʻohana	Rivaroxaban (CAS: 366789-02-8) Kūwaena

(S)-(+)-Glycidyl Phthalimide CAS: 161596-47-0 Alanui Synthesis

Pūʻolo a me ka waiho ʻana:

Pono:

FAQ:

Noi:

ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui a me ka mea hoʻolako o (S)-(+)-Glycidyl Phthalimide (CAS: 161596-47-0) me ke kūlana kiʻekiʻe.He mea waena maʻamau i ka synthesis o Rivaroxaban (CAS: 366789-02-8), i ka mālama ʻana i ka Venous Thromboembolism (VTE).

ʻO Rivaroxaban (Xarelto; CAS: 366789-02-8) kahi lāʻau antithrombotic a ua hoʻomohala ʻia ma ka hui pū ʻana ma waena o ka German Bayer Pharmaceuticals a me ka hui ʻo American Johnson.Hōʻike ʻia ʻo Rivaroxaban no ka mālama ʻana i ka thrombosis vein hohonu a me ka embolism pulmonary, a me ka pale ʻana i ka thrombosis hohonu hohonu a me ka pulmonary embolism i nā pākeke.